Targeting the PD-L1/DNMT1 axis in acquired resistance to sorafenib in human hepatocellular carcinomaJianhua Liu, Bai Ji|Oncology Reports|2017Cited by 92
Gold nanoparticles-loaded anti-miR221 enhances antitumor effect of sorafenib in hepatocellular carcinoma cellsHongqiao Cai, Bai Ji|International Journal of Medical Sciences|2019Cited by 38